Sign in

CIK 0000725363

  • Non-accelerated filer
  • Smaller reporting company

CEL SCI CORP

Sign in to watch
Ticker
CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
CO
Entity type
Operating
EIN
840916344
Phone
+1 703-506-9460
Business address
8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
  1. 4 Grant or award CEO acquired 12,940 shares (grant or award)
  2. 4 Grant or award Chief Scientific Officer acquired 6,001 shares (grant or award)
  3. 4 Grant or award Chief Financial & Operations acquired 10,727 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 2,264 shares (grant or award)
  5. 4 Grant or award Sr. VP of Operations acquired 4,047 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 4,882 shares (grant or award)
  7. 4 Grant or award Chief Scientific Officer acquired 2,068 shares (grant or award)
  8. 4 Grant or award Senior Vice President acquired 3,698 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 4,461 shares (grant or award)
  10. 4 Open-market buy Director bought 20,000 shares at $1.39 ($27,800)
  11. 4 Open-market buy Senior Vice President bought 8,000 shares at $1.39 ($11,120)
  12. 4 Open-market buy Chief Executive Officer bought 30,000 shares at $1.39 ($41,700)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Scientific Officer acquired 1,256 shares (grant or award)
  20. 4 Grant or award Senior Vice President acquired 2,246 shares (grant or award)

Page 3 of 41 · 806 filings